Synthesis and antiviral activity of 2'-deoxy-4'-thio purine nucleosides. 1996

N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
Division of Experimental Therapy, Burroughs Wellcome Company, Research Triangle Park, North Carolina 27709, USA.

A series of 2'-deoxy-4'-thioribo purine nucleosides was prepared by trans-N-deoxyribosylase-catalyzed reaction of 2'-deoxy-4'-thiouridine with a variety of purine bases. This synthetic procedure is an improvement over methods previously used to prepare purine 4'-thio nucleosides. The compounds were tested against hepatitis B virus (HBV), human cytomegalovirus (HCMV), herpes simplex virus (HSV-1 and HSV-2), varicella zoster virus (VZV), and human immunodeficiency virus (HIV-1). Cytotoxicity was determined in a number of cell lines. Several compounds were extremely potent against HBV and HCMV and had moderate to severe cytotoxicity in vitro. The lead compound from the series, 2-amino-6-(cyclopropylamino)purine 2'-deoxy-4'-thioriboside, was the most potent and selective agent against HCMV and HBV replication in vitro; however, this analogue was nephrotoxic when tested in vivo.

UI MeSH Term Description Entries
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
January 1999, Nucleosides & nucleotides,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
August 1991, Journal of medicinal chemistry,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
January 2009, Nucleic acids symposium series (2004),
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
June 2010, Chemical biology & drug design,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
January 2005, Nucleosides, nucleotides & nucleic acids,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
January 2005, Nucleosides, nucleotides & nucleic acids,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
September 1991, Journal of medicinal chemistry,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
January 1999, Nucleosides & nucleotides,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
March 1999, Bioorganic & medicinal chemistry,
N A Van Draanen, and G A Freeman, and S A Short, and R Harvey, and R Jansen, and G Szczech, and G W Koszalka
July 2000, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!